The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A 2A adenosine receptor antagonists
Data up to Jan 2025
Total Citations Per Year
Abstract
References (55)
Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
1985 • 5,596 citations
The use of a plus-maze to measure anxiety in the mouse
1987 • 2,571 citations
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.
1999 • 2,431 citations
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 • 1,392 citations
ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS
1979 • 1,370 citations
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
1997 • 906 citations
Adenosine receptors and behavioral actions of methylxanthines.
1981 • 705 citations
Selective Amplification And Cloning Of Four New Members Of The G Protein-coupled Receptor Family
1989 • 647 citations
Adenosine, Adenosine Receptors and the Actions of Caffeine *
1995 • 563 citations
Exploration of mice in a black and white test box: Validation as a model of anxiety
1989 • 535 citations
Adenosine receptor activation and nociception
1998 • 478 citations
Increased Anxiogenic Effects of Caffeine in Panic Disorders
1985 • 427 citations
Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans
1997 • 364 citations
The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist
1995 • 361 citations
Adenosine receptor ligands: differences with acute versus chronic treatment
1996 • 267 citations
Anxiety or Caffeinism: A Diagnostic Dilemma
1974 • 264 citations
Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents
1998 • 205 citations
Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors
1988 • 194 citations
Increased Sensitivity to Caffeine in Patients With Panic Disorders
1984 • 190 citations
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
1999 • 185 citations
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease
1998 • 160 citations
Caffeine tolerance and choice in humans
1992 • 151 citations
Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitors
1982 • 138 citations
Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration
1995 • 129 citations
Interactions in the behavioral effects of methylxanthines and adenosine derivatives.
1983 • 128 citations
Anxiolytic activity of adenosine receptor activation in mice
1995 • 127 citations
Anxiogenic action of caffeine: an experimental study in rats
1997 • 124 citations
Reinforcing effects of caffeine in humans.
1988 • 120 citations
Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes
1992 • 119 citations
Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists
1998 • 115 citations
Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines
1983 • 108 citations
Reinforcing and subjective effects of caffeine in normal human volunteers
1989 • 101 citations
Caffeine: relationship to human anxiety, plasma MHPG and cortisol.
1984 • 95 citations
Emetic, central nervous system and pulmonary activities of rolipram in the dog
1995 • 93 citations
Caffeine-induced anxiogenesis: The role of adenosine, benzodiazepine and noradrenergic receptors
1989 • 86 citations
Antagonistic effects of caffeine and yohimbine in animal tests of anxiety
1989 • 85 citations
Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze
1990 • 80 citations
Adenosine A 1 receptors modulate anxiety in CD1 mice
1998 • 79 citations
Long‐term Treatment with some Methylxanthines Decreases the Susceptibility to Bicuculline‐ and Pentylenetetrazol‐induced Seizures in Mice. Relationship to c‐ios Expression and Receptor Binding
1996 • 73 citations
Anxiogenic effects of caffeine on panic and depressed patients
1988 • 72 citations
Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX
1991 • 70 citations
Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain
1985 • 66 citations
Behavioral and physiological effects of xanthines in nonhuman primates
1997 • 66 citations
Behavioral effects of acute and chronic administration of caffeine in the rat
1988 • 63 citations
Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding
1992 • 63 citations
Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
1998 • 62 citations
Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy.
1992 • 45 citations
Dose‐response effects of intravenous caffeine in normal volunteers
1994 • 44 citations
Consumption of coffee or tea and symptoms of anxiety.
1984 • 41 citations
Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors.
1994 • 34 citations
Antagonism of the anti-conflict effects of phenobarbital, but not diazepam, by the A-1 adenosine agonistl-PIA
1990 • 21 citations
The anxiogenic effects of caffeine.
1990 • 20 citations
Plasma adenosine levels: Measurement in humans and relationship to the anxiogenic effects of caffeine
1987 • 20 citations
Knockouts anxious for new therapy
1997 • 12 citations
Hypothermic effects of alkylxanthines: evidence for a calcium-independent phosphodiesterase action
1991 • 11 citations